The GOLD 2023 and 2024 reports recommend that health professionals consider triple therapy (TT) entailing combined use of a long-acting β 2 agonist (LABA), a long-acting muscarinic antagonist (LAMA), ...
Please provide your email address to receive an email when new articles are posted on . The 2023 Global Initiative for Chronic Obstructive Lung Disease report defines several changes regarding ...
The 2025 Global Initiative for Chronic Obstructive Lung Disease (GOLD) report highlighted climate change, cardiovascular risk, and pulmonary hypertension. Claus F. Vogelmeier, MD, chair of the GOLD ...
Credit: Getty Images. The 2024 GOLD COPD Report includes updated research and recommendations that reflect shifts in thinking on COPD management. Vogelmeier, who heads the Department of Medicine, ...
Please provide your email address to receive an email when new articles are posted on . Spirometry, treatments, telemedicine and multimorbidity are notable topics at this year’s GOLD International ...
More than 50% of adults with low pulmonary function are undiagnosed and unaware that they have COPD. Alpha-1 antitrypsin deficiency (AATD) is also a rare genetic disorder that causes COPD. 4 Alpha-1 ...
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) and the Global Lung Function Initiative (GLI) have published a joint statement on the use and interpretation of spirometry for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results